UnknownPhase 2NCT00244179

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Studying Reactive arthritis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Charite University, Berlin, Germany
Principal Investigator: joachim sieper, prof.
charite, campus benjamin franklin, rheumatology, berlin
Intervention: interferon-gamma(drug)
Enrollment: 40 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2003

Study locations (1)

Charite Campus Benjamin Franklin, Rheumatology, Berlin, Germany

Collaborators

dfg

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00244179 on ClinicalTrials.gov

Other trials for Reactive arthritis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center

See all trials for Reactive arthritis →

← Back to all trials